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Abstract 
Background: Randomised controlled trials are widely acknowledged as the gold standard in medical research 
although their validity can be undermined by non-compliance with the randomly allocated treatment and missing 
data. Due to the nature of the intervention, surgical trials face particular threat to compliance and data collection. 
For example, ineligibility for the intervention may only become apparent once the operation has commenced. It is 
unclear how such cases are reported and handled.
Objective: The objective was to assess non-compliance and missing data in reports of trials of surgical interventions.
Methods: Searches for reports of trials involving at least one surgical procedure and published in 2010 were carried 
out in the Medical Literature Analysis and Retrieval System Online (MEDLINE®). Data on missing data, non-compliance 
and methods of handling missing data were extracted from full texts. Descriptive data analyses were carried out on 
the data.
Results: Forty-five (55 %) studies reported non-compliance with treatment allocation and 52 (63 %) reported primary 
outcome missing data. The median levels of non-compliance and missing data were 2 % [IQR (0, 5), range (0–29)] and 
6 % [IQR (0, 15), range (0–57)], respectively. Fifty-two (63 %) studies analysed as randomised, 17 (21 %) analysed per 
protocol and 3 (4 %) analysed as treated. Complete case analysis was the most common method used to deal with 
missing data, 35/52 (67 %).
Conclusions: The reporting of non-compliance to allocation and the handling of missing data were typically subop-
timal. There is still room for improvement on the use of the CONSORT statement particularly in accounting for study 
participants. Transparency in reporting would facilitate evidence synthesis.
Keywords: Missing data, Non-compliance, Intention-to-treat, Surgical trials
© 2015 Adewuyi et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
A randomised controlled trial (RCT) is the optimal type 
of experimental design [1] for evaluating causal effect of 
treatments. High quality RCTs with very low risk of bias 
serve as first level evidence in evidence-based medicine 
[2]. However, the theoretical advantages of the RCT design 
can be undermined by non-compliance to the treatment 
and group allocation and missing data, potentially intro-
ducing bias and therefore applying the findings becomes 
problematic. Over recent years there has been growing 
awareness of the importance of these issues and methodo-
logical development [3, 4]. Trials of surgical interventions 
have been criticised in part due to concerns about their 
ability to account for the complexity of surgery, the role 
and influence of the surgeon along with potentially strong 
patient preference and challenges in outcome measure-
ment. Difficulties include achieving adequate sample size 
and potentially higher levels of non-compliance because 
Open Access
*Correspondence:  t.e.adewuyi.15@aberdeen.ac.uk 
Health Services Research Unit, University of Aberdeen, Foresterhill, 
Aberdeen AB25 2ZD, Scotland, UK
Page 2 of 10Adewuyi et al. BMC Res Notes  (2015) 8:403 
participants are at liberty to seek their preferred treatment 
option outside the trial [5]. Empirical evidence suggests 
that surgical expertise (in terms of both individual and 
surgical community learning curves) may cause deviation 
from allocated procedures [6–8].
Unlike pharmacological trials where temporary or per-
manent discontinuation of study drug constitutes non-
compliance [9], surgical trials are particularly prone to 
other forms of non-compliance as a result of the chal-
lenges involved in their design and implementation. 
Causes of non-compliance and missing data in surgical 
trials include changes in treatment option at the surgeon’s 
discretion or for other clinical indications; failure of sur-
geons to adhere strictly to protocol by performing the 
same procedure but with modifications because of vari-
able surgical expertise or in an attempt to tailor the inter-
vention to the individual needs of the patient; change to 
the alternative surgical procedure if the surgeon is not in 
equipoise in terms of skill; failure to receive the allocated 
treatment because surgery was deemed unnecessary or 
impossible after gaining surgical access; refusal of surgery 
whereby a participant does not give consent for surgery 
but is otherwise happy to continue in the study; death 
before surgery; and withdrawal of consent for participa-
tion in the trial after randomisation but before surgery 
is received. Treatment changes may be to another treat-
ment being evaluated within the trial or to treatments 
outwith the trial protocol. It is unclear how non-com-
pliance and missing data are reported and accounted for 
in surgical trials. Randomisation must be accompanied 
by analysis of data that include unbiased measurements 
and ignorable missing values for attribution to be made 
[10]; therefore, inappropriate methods of handling miss-
ing data could lead to false conclusions. Different meth-
ods of handling missing data are employed in different 
situations and the effect of different approaches on the 
estimates should be considered because different meth-
ods can produce results that vary not only in magnitude 
but also in direction [11, 12]. The main aims of this study 
were to assess the level of non-compliance and missing 
data in surgical trials, and also to describe the methods 
used to account for this. Additionally, we aimed to show 
whether the level of these occurrences varied according 
to the type of surgical trial (see below for definitions).
Methods
Systematic searches for relevant surgical trials published 
in 2010 in the general medical (GMJs) and surgical jour-
nals (SJs) were carried out in MEDLINE® from incep-
tion till 31st March 2011 (see Additional file 1). Six GMJs 
(The British Medical Journal, Journal of the American 
Medical Association, The Lancet, New England Journal 
of Medicine, Archives of Internal Medicine and Annals of 
Internal Medicine) and 12 SJs (British Journal of Surgery, 
American Journal of Surgery, Annals of Surgery, Archives 
of Surgery, World Journal of Surgery, International Jour-
nal of Surgery, The Journal of Bone and Joint Surgery 
(American), The Journal of Bone and Joint Surgery (Brit-
ish), British Journal of Urology International, Journal of 
Urology, Obstetrics and Gynecology, American Journal of 
Obstetrics and Gynecology and British Journal of Obstet-
rics and Gynaecology International) were searched. Pri-
mary reports of two-arm randomised controlled trials 
involving at least one surgical procedure were included. 
Studies comparing the timing of administration of the 
same surgical procedure were excluded because the tim-
ing of intervention was not the unit of comparison in 
this review. Those comparing alternatives within the 
same participant (within-patient randomisation) were 
excluded because it would be impossible to assess dif-
ferential attrition between groups. Secondary reports of 
the same study as well as pilot and feasibility studies were 
excluded because the aim was to assess primary reports 
on the same basis. Non-randomised studies, systematic 
reviews and non-English language papers were excluded.
Cook [6] defines surgical interventions as ‘those which 
involve physically changing body tissues and organs 
through manual operation such as cutting, abrading, 
suturing or the use of lasers’. Wente et  al. [8] described 
two types of surgical trials: (1) those focusing on surgi-
cal procedures and (2) those focusing on other aspects 
of surgery such as anaesthesia or pharmacological 
and adjuvant treatments in surgical patients. The first 
group, which this review will be examining, can be fur-
ther divided into four types of comparisons: (1) those 
comparing surgical procedure with placebo surgery, for 
example arthroscopic debridement versus sham surgery 
for osteoarthritis; (2) those comparing similar surgical 
procedures, for example use of reamed or unreamed nails 
for fixation of tibial fractures; (3) those comparing sub-
stantially different surgical procedures, for example open 
versus laparoscopic hernial repair; and (4) those compar-
ing surgical with non-surgical management, for example 
surgery versus medicine in the treatment of gastroesoph-
ageal reflux disease or surgery versus physiotherapy for 
the management of anterior cruciate ligament injury.
The percentage of participants with non-compliance 
with treatment allocation and missing primary out-
come data and the primary and secondary methods for 
handling missing data in the primary analysis of the pri-
mary outcome were determined for each study. For the 
purpose of this study, missing data included any primary 
outcome data that were not collected for randomised 
participants and any data excluded from analysis, for 
example, participants who were randomised and subse-
quently excluded due to ineligibility (post randomisation 
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exclusions). Methods for handling missing data were 
determined either from the text or denominators in 
the tables and figures. The occurrence and level of non-
compliance were deduced from the methods of analysis 
reported when these were not reported in the text. A 
definition of the terms related to the methods of analysis 
that were reviewed are presented in Table 1.
All titles and abstracts and full texts were screened by 
two independent reviewers. Data were double extracted 
by two independent reviewers using a data extraction 
form that was designed for the review and which had 
been piloted on 10  % of the included studies. Discrep-
ancies were resolved by discussion or arbitration by the 
third reviewer. Two independent reviewers ran descrip-
tive statistical analyses (mean, median, frequency and 
proportion) on the data using Stata 13 (StataCorp. 2013. 
Stata Statistical Software: Release 13. College Station, 
TX: StataCorp LP). The review protocol was not regis-
tered and it is available from the authors.
Results
Eighty-two studies were included from 131 full texts 
screened. Figure  1 outlines the identification of poten-
tially eligible studies and the reasons for exclusion while 
Table 2 summarises their characteristics. 
Description of included studies
Of 82 included studies, 49(60  %) compared similar sur-
gical procedures [13–61], 17 compared substantially dif-
ferent procedures [62–78], 15 compared surgical and 
non-surgical management [79–93] and one compared 
surgery with placebo [94]. Most reports were of sin-
gle centre RCTs, the median number of participants 
recruited was 108 [IQR 65, 200].
Non‑compliance
Forty-five (55  %) studies reported non-compliance with 
treatment allocation; it was unclear in 11 (13  %) stud-
ies. In the 68 studies where the level of non-compliance 
could be derived (including 26 studies with zero non-
compliance) the median percentage was 2  % [IQR (0, 
5  %), range (0–29  %)], see Table  3. The reported analy-
sis strategies were 52 (63 %) analysed as randomised, 17 
(21 %) per-protocol and 3 (4 %) as-treated. The method of 
primary analysis was unclear in 10 (12 %) studies. Of the 
31 studies which explicitly stated that the analysis was by 
intention-to-treat, 20 (65 %) included all participants in 
the analysis and analysed as randomised.
Missing data
Fifty-two (63 %) studies reported having missing primary 
outcome data. In 7 (9 %) studies, it was unclear whether 
there were missing data. The median level of missing pri-
mary outcome data (including studies with zero missing 
data) was 6 % [IQR (0, 15), range (0–57)], see Table 3. The 
most common analysis strategy when missing data were 
present was complete case analysis, 35/52 (67 %). Meth-
ods used to account for missing data were survival type 
analysis to deal with censoring (4, 8  %); baseline or last 
observation carried forward (4, 8 %); imputing best case 
scenario (3, 6 %); and imputing best and worst case sce-
narios (2, 4  %). Multiple imputation and mixed models 
were used by 4 (8 %) studies (Table 4).
Non‑compliance, missing data and types of surgical trials
Clear reporting of the occurrence or otherwise of non-
compliance was observed in 40/49 (82  %), 14/17 (82  %) 
and 13/15 (87  %) comparisons between similar surgical 
procedures, substantially different surgical procedures 
and between surgical and non-surgical management, 
respectively. The median levels were 1  % [IQR (0, 3), 
range (0–3)], 4  % [IQR (1, 10), range (0–29)], and 4  % 
[IQR (0, 6), range (0–10)], respectively.
The level of missing data could be derived (includ-
ing those with zero missing data) in 45/49(92  %), 15/17 
(88  %) and 13/15 (87  %) comparisons between similar 
surgical procedures, substantially different surgical pro-
cedures and between surgical and non-surgical manage-
ment, respectively. The medians were 5  % [IQR (0, 13), 
range (0–57)], 0 % [IQR (0, 14), range (0–27)], and 14 % 
[IQR (6, 17), range (0–46)], respectively.
Discussion
The CONSORT statement [95] and the CONSORT state-
ment extension for RCTs of non-pharmacological treat-
ments [96] provide a means of ensuring transparency in 
reporting RCTs as well as non-pharmacological RCTs 
which have peculiar challenges in specific areas such as 
Table 1 Definition of terms
Terms Definition
As-randomised analysis All participants were analysed in the groups they were originally allocated to, irrespective of the treatment they received
Per-protocol analysis Participants who deviated from treatment allocation were excluded from the analysis
As-treated analysis Participants were analysed according to the treatment they received
Intention-to-treat All participants were analysed in the group they were originally randomly allocated to, irrespective of the treatment they 
received and where there are missing data, they are accounted for
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blinding, standardisation of interventions and care pro-
vider expertise.
This review shows that non-compliance and missing 
data commonly occur in surgical trials but the reported 
levels are typically low where reported. The occurrence 
and level of non-compliance were comparable among the 
three types of trials (82–87  %, 1–4  %). The occurrence 
of missing data was similar (88–92  %) across the types 
of surgical trials while the level varied from 0 % between 
substantially different surgical procedures, to 5 % between 
similar surgical procedures and 14 % between surgical and 
non-surgical management. In about a sixth of studies, the 
extent of reporting was not sufficient to allow assessment 
of the occurrence of non-compliance and missing data. A 
recent study [97] found an overall level of loss to follow-
up (6 %, IQR 2–14 %) across studies of pharmacological 
versus surgery/invasive procedure versus other interven-
tions which is similar to that found in our study.
It is well known that many cases of non-compliance 
result in missing data and this was also observed in the 
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current study. We suspected that the occurrence of non-
compliance and hence missing data would be higher 
when surgical procedures were compared with non-sur-
gical interventions such as medicine, active surveillance 
and physiotherapy due to patient preference particularly 
when blinding is impractical or between substantially 
different surgical procedures such as open versus lapa-
roscopic procedures which may be due to differences in 
surgical skill, experience and flexibility in unexpected 
situations such as rare anatomical findings. Our find-
ings suggest that non-compliance is more likely in RCTs 
of surgical versus non-surgical management. We have 
not identified similar studies with which to compare our 
findings.
In most of the studies where it was impossible to ascer-
tain whether a type of non-compliance or missing data 
occurred, this was because the authors had not fully 
accounted for all randomised participants and/or given 
Table 2 Description of included studies
Characteristic Descriptive statistics  
n (%) unless otherwise 
stated N = 82
Type of trial
 Similar surgical procedures 49 (60)
 Substantially different procedures 17 (21)
 Surgical versus non-surgical management 15 (18)
 Surgery versus placebo surgery 1 (1)
Number of centres and operators
 Single centre 48 (59)
 Multi-centre 32 (39)
 Unclear 2 (2)
Operators in single centre RCTs
 Unclear 20/48 (42)
 More than one operator but unclear 3/48 (6)
 Number of operators reported 25/48 (52)
 Median number of operators in single  
centre RCTs
2
 [25th, 75th centiles] [1, 3]
 (Min, max) (1, 20)
Operators in multi-centre RCTs
 Unclear 26/32 (81)
 Number of operators reported 6/32 (19)
 Median number of operators in  
multi-centre RCTs
5
 [25th, 75th centiles] [5, 6]
 (Min, max) (4, 701)
Number participants
 Median 108
 [25th, 75th centiles] [65, 200]
 (Min, max) (15, 2522)
Region
 Africa 3 (4)
 America 16 (20)
 Asia 11 (13)
 Australasia 3 (4)
 Europe 43 (52)
 Intercontinental 5 (6)
 Unclear 1 (1)
Table 3 Non-compliance and missing data
a 3 studies where non-compliance was reported but it was not possible to 
derive the percentage of participants and 11 studies where non-compliance was 
unclear
b 1 study where missing data were reported but it was not possible to derive 
the percentage of participants and 7 studies where missing data were unclear
Outcome Descriptive statistics n (%) 
unless otherwise  
stated N = 82
Non-compliance with allocated intervention
 Yes 45 (55)
 No 26 (32)
 Unclear 11 (13)
Percentage of non-compliance
 In all studies N; median 68a; 2
 [25th, 75th centiles] [0, 5]
 (Min, max) (0, 29)
 Only in studies with non-compliance N; 
median
42a; 4
 [25th, 75th centiles] [2, 7]
 (Min, max) (1, 29)
Missing data for primary outcome
 Yes 52 (63)
 No 23 (28)
 Unclear 7 (9)
Percentage of missing data
 In all studies N; median 74b; 6
 [25th, 75th centiles] [0, 15]
 (Min, max) (0, 57)
 Only in studies with missing data. N; 
median
52b; 12
 [25th, 75th centiles] [6, 19]
 (Min, max) (0, 57)
Table 4 Methods used to account for missing data
a Number of studies where missing data were reported; percentages do not add 
up to 100 because of rounding
Missing data method n (%) N = 52a
Complete case analysis 35 (67)
Survival type analysis 4 (8)
Baseline/last observation carried forward 4 (8)
Imputation of best case scenario 3 (6)
Imputation of best and worst case scenarios 2 (4)
Multiple imputation and mixed models 4 (8)
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clear reasons for non-compliance and/or exclusions 
from analysis. When the levels of non-compliance and 
missing data were unquantifiable, this was because the 
authors reported that there were missing data and non-
compliance but we could not quantify the numbers with 
missing data or non-compliance because the authors had 
presented the results in percentages and either the num-
ber randomised into each group had not been reported 
or the number analysed was unclear. On occasion, it was 
observed that only the number of participants included 
in the analysis was reported while the numbers ran-
domised into treatment groups were not reported. In 
addition, many authors reported the overall number of 
participants with non-compliance and/or missing data as 
a proportion of all participants in the study rather than 
as a proportion of the participants in each intervention 
group as stipulated by the CONSORT statement [96, 98].
Some non-compliance and missing data are almost 
inevitable, therefore it is important that investigators 
define adequately what the intervention is and specify 
reasons for non-compliance and address missing data. 
Reporting the timing of non-compliance or loss to fol-
low-up was often ambiguous thus making it difficult to 
ascertain whether or not patients allocated to surgical 
interventions received the intervention or the period of 
time that patients who were allocated to medical inter-
ventions defaulted from treatment. Akl et al. [97] found 
that the accuracy of abstracted information varied 
from 84 to 100 % depending on the clarity of reporting 
in reports of RCTs of pharmacological versus surgery/
invasive procedure versus other interventions. In order 
for readers not to misjudge poor reporting as poor 
methodology, clarity and transparency in reporting is 
essential. Furthermore, the reason for missingness is 
important in choosing an appropriate method for han-
dling missing data. When data are missing completely 
at random (MCAR), for example, if a participant moves 
abroad and outcome data cannot be collected, the rea-
son for missingness is not influenced by the prognosis or 
the study, neither is it related to the missing value itself 
[99] and as such, the difference between the observed 
data and the hypothetically complete data is random 
and exclusion of missing data would not introduce bias 
but there will be loss of power [99, 100]. When data are 
missing at random (MAR), the difference between the 
observed data and the hypothetically complete data 
is systematic. The reason for missingness on that vari-
able cannot be explained by the missing value itself but 
rather by the information available on other variables 
[99] and as such, deletion of missing data would not be 
justified. For example, if it is known that older partici-
pants tend to ignore a certain question in a survey, one 
could explain that the reason for missingness is the age 
of the participant but this reason is non-informative or 
ignorable because it still does not explain why older par-
ticipants ignore the question. In such situations, there 
are methods that could handle the missing data and a 
model is not required [100]. Missing not completely at 
random (MNAR) is when data is missing in a system-
atic fashion, the probability of missingness depends 
on the missing value itself [99, 100] and the reason for 
missingness is informative or non-ignorable because it 
is related to the prognosis. In this situation a model is 
required to explain the missingness and handle it in the 
analysis [100]. Authors need to investigate and report 
reasons for missingness so as to justify the appropriate-
ness of the methods of handling missing data as well as 
the possible implications missing data may have on the 
findings.
There appears to be a lack of consistency in the termi-
nologies used in reporting missing data and non-com-
pliance. However, a better understanding of the purpose 
of the CONSORT flow chart and strict adherence to the 
guidance template would definitely give some clarity in 
the numbers randomised, treated, followed up and ana-
lysed; this finding is supported by previous studies [97, 
101, 102]. Akl et  al. [97] showed that 87  % of reviewed 
studies explicitly reported information on loss to follow-
up or presented it in a CONSORT flow diagram or both. 
The current review found that 91  % of studies reported 
the occurrence or otherwise of missing data explicitly, 
using a CONSORT flow chart or the reviewers obtained 
relevant information by calculating denominators from 
raw figures and percentages in result tables.
About two-thirds of reviewed studies analysed as ran-
domised while some performed per-protocol analy-
sis and few analysed as treated. Exclusion of data could 
introduce bias or give an estimate that is applicable to the 
sub-population of participants that completed the study. 
The choice between intention-to-treat (ITT) and per-
protocol depends on the objective of the study, which is 
whether it sets out to establish equivalence of two inter-
ventions or the superiority of one over the other. In order 
to avoid presenting a harmful or equivalent as harmless, 
equivalent or superior, a per-protocol analysis is more 
appropriate as an ITT analysis is conservative. In addi-
tion, authors may use a per-protocol analysis to handle 
non-compliance [103] but an ITT analysis is the stand-
ard analysis and should be presented as well [104]. Of 17 
studies that reported per-protocol analysis only, only one 
[105] was an equivalence trial and the authors also pre-
sented an ITT analysis. Previous studies [102, 106] dem-
onstrated that reporting of an ITT analysis was far more 
common (48, 83 %) than its use (13, 22 %) while the cur-
rent review showed that more authors are beginning to 
use the term properly as 65 % of studies reporting an ITT 
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analysis were found to have analysed all randomised par-
ticipants as-randomised.
The vast majority of studies with missing data used 
simple methods of handling missing data such as com-
plete case analysis and simple imputation despite the 
widespread availability of more robust methods. While 
levels of missing data were generally low, some studies 
had large levels for which the use of more complex meth-
ods could be particularly useful.
This review is limited by the sample size and the lim-
ited range of sources of the included studies and as such 
our findings may not be generalizable to all journals. In 
addition, the extent to which compliance and missing 
data could be evaluated was dependent upon the stand-
ard of reporting, which was suboptimal.
Recommendations for authors
Based on our findings, we recommend that authors 
should account for all participants who were assessed 
for eligibility at every stage of the trial and the num-
bers should also be clearly documented in the text as 
well as in the CONSORT flow chart. Authors should 
endeavour to investigate the reasons for missing data 
and non-compliance with treatment allocation for all 
randomised participants and report these reasons with 
the number of participants in the text as well as in the 
CONSORT flow chart. It is crucial that this is done per 
treatment arm. Authors should also report the time in 
the course of the trial when the missing data occurred 
and indicate this at the appropriate stage in the CON-
SORT flow chart. Finally, the analysis strategy should be 
described clearly rather than described with terms such 
as “intention-to-treat” which could vary in meaning.
Conclusions
Non-compliance and missing data commonly occur in 
surgical trials but typically low levels. Reporting of non-
compliance and missing data is sub-optimal and there is 
room for improvement in reporting standards. Authors 
should be encouraged to use more robust methods of 
handling missing data. Lack of transparency in reporting 
may hinder users of research findings from making valid 
decisions and could raise questions about the integrity of 
a trial.
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